3-Fluoro-2-Formylphenylboronic Acid

We are 3-Fluoro-2-Formylphenylboronic Acid CAS:871126-15-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Product Name: 3-Fluoro-2-Formylphenylboronic Acid
Other Name:
3-Fluoro-2-Formylphenylboronic Acid
(3-Fluoro-2-formylphenyl)boronic acid
CAS No: 871126-15-7
MF: C7H6BFO3
MW: 167.93000
Density: 1.3±0.1 g/cm3
Boiling point: 357.4±52.0 °C at 760 mmHg
Melting point: 123-127ºC
Flash point: 169.9±30.7 °C
Refractive index: 1.524
UN Number: UN3261
UN Proper Shipping Name: ADR/RID: CORROSIVE SOLID, ACIDIC, ORGANIC, N.O.S.
Transport hazard class: 8
Packing group: III
 
Specification
Appearance: Off-white to white powder
Assay: ≥98.0%
Water: ≤0.50%
 
Application
Applicationd as an OLED intermediate, organic intermediate, pharmaceutical intermediate.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

3-Fluoro-2-Formylphenylboronic Acid


Related News: The API can be directly formulated, and the intermediate can only be used to synthesize the next product. Only through the intermediate can the API be manufactured.ácido ciclobutano-1,1-dicarboxílico CAS:5445-51-2 In 2004, the National Development and Reform Commission, the former Ministry of Health, and the Ministry of Finance jointly formulated and promulgated the Administrative Measures for the Configuration and Use of Large Medical Equipment. This method uses X-ray electronic computer tomography (CT) devices and medical magnetic resonance imaging equipment, digital subtraction angiography X-ray machines of 800 mA or more as the management products of large-scale medical equipment, Purchase and use need to be reported to the provincial health administrative department for approval before approval. However, in recent years, with the comprehensive coverage of medical insurance, such basic medical facilities are being widely popularized, and the relevant implementation rules have directly linked the number of equipment to the number of doctors. Therefore, as the demand for imaging equipment continues to increase, it will have a greater boosting effect on the upstream contrast agent and its raw material market.22134-07-2 In 2004, the National Development and Reform Commission, the former Ministry of Health, and the Ministry of Finance jointly formulated and promulgated the Administrative Measures for the Configuration and Use of Large Medical Equipment. This method uses X-ray electronic computer tomography (CT) devices and medical magnetic resonance imaging equipment, digital subtraction angiography X-ray machines of 800 mA or more as the management products of large-scale medical equipment, Purchase and use need to be reported to the provincial health administrative department for approval before approval. However, in recent years, with the comprehensive coverage of medical insurance, such basic medical facilities are being widely popularized, and the relevant implementation rules have directly linked the number of equipment to the number of doctors. Therefore, as the demand for imaging equipment continues to increase, it will have a greater boosting effect on the upstream contrast agent and its raw material market.4-Amino-2-Fluorobenzotrifluoride In 2004, the National Development and Reform Commission, the former Ministry of Health, and the Ministry of Finance jointly formulated and promulgated the Administrative Measures for the Configuration and Use of Large Medical Equipment. This method uses X-ray electronic computer tomography (CT) devices and medical magnetic resonance imaging equipment, digital subtraction angiography X-ray machines of 800 mA or more as the management products of large-scale medical equipment, Purchase and use need to be reported to the provincial health administrative department for approval before approval. However, in recent years, with the comprehensive coverage of medical insurance, such basic medical facilities are being widely popularized, and the relevant implementation rules have directly linked the number of equipment to the number of doctors. Therefore, as the demand for imaging equipment continues to increase, it will have a greater boosting effect on the upstream contrast agent and its raw material market.In 2004, the National Development and Reform Commission, the former Ministry of Health, and the Ministry of Finance jointly formulated and promulgated the Administrative Measures for the Configuration and Use of Large Medical Equipment. This method uses X-ray electronic computer tomography (CT) devices and medical magnetic resonance imaging equipment, digital subtraction angiography X-ray machines of 800 mA or more as the management products of large-scale medical equipment, Purchase and use need to be reported to the provincial health administrative department for approval before approval. However, in recent years, with the comprehensive coverage of medical insurance, such basic medical facilities are being widely popularized, and the relevant implementation rules have directly linked the number of equipment to the number of doctors. Therefore, as the demand for imaging equipment continues to increase, it will have a greater boosting effect on the upstream contrast agent and its raw material market.

Related Products
Product Name
4,4-Diethoxy-N,N-dimethyl-1-butanamine View Details
2,6-dichlorobenzenethiol View Details
2,6-Dihydroxybenzoic acid View Details
3-Chlorobenzoyl chloride manufacturer 2,5-Dichloro-N-(2-(isopropylsulfonyl)phenyl)pyrimidin-4-amine manufacturer Catechol manufacturer 2-Methoxyethanol manufacturer Bromotris(dimethylamino)phosphonium hexafluorophosphate manufacturer